Bowman-Birk inhibitor product for use as an anticarcinogenesis a

Details Bowman-Birk inhibitor product for use as an anticarcinogenesis a Bowman-Birk inhibitor product for use as an anticarcinogenesis a

1992-11-02

1994-08-16

Rollins, John W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

514783, A61K 3578, A61K 4700

Patent

active

053385470

ABSTRACT:
Methods for the suppression and inhibition of carcinogenesis are provided in which a Bowman-Birk product produced in accordance with the processes described are administered. The methods are particularly adaptable to the prevention or treatment of colon, lung, liver, esophagus, oral epithelium (squamous carcinomas), and bone marrow cancer. The preferred mode of administration is as a dietary supplement.

REFERENCES:
patent: 3365440 (1968-01-01), Circle et al.
patent: 4793996 (1988-12-01), Kennedy et al.
Baturay et al., Cell Biology and Toxicology 1986, 2, 21-32.
Berenblum et al., Radiat. Res. 1974, 60, 501-505.
Billings et al., Carcinogenesis 1990, 11, 1083-1086.
Bowman, Proc. Soc. Exptl. Med. 1946, 63, 547-550.
Birk et al., Bull. Res. Council Israel 1962, Sec. A 11, 48.
Birk, Biochim. Biophys. Acta 1963, 67, 326-328.
Hwang et al., Biochem. Biophy. Acta. 1977, 495, 369-382.
Methods Enzymol 1970, 19, 860-862.
Kennedy et al., Proc. Natl'l. Acad. Sci. USA 1984, 81, 1827-1839.
Kennedy et al., Anticarcinogenesis and Radiation Protection, Cerutti et al., Eds., Plenum Pub, 1987, pp. 285-295.
Kennedy, A. R. Mechanisms of Tumor Promotion vol. III, T. J. Slaga, Eds., CRC Press, 1984, Chapter 2, pp. 13-55.
Messadi et al., J. Natl. Cancer Inst. 1986, 76, 447-452.
Morris, J. Dent. Res. 1961, 40, 3-15.
M. Naim et al., Br. J. Nutr. 1982, 47, 281-288.
Odani and Ikenaka, J. Biochem. 1973, 74, 857.
Perlmann et al., Methods in Enzymology 1970, 19, 860-862.
Salley, J. Dent. Res. 1954, 33, 253-262.
St. Clair et al., Cancer Res. 1990, 50, 580-586.
von Hofe et al., Carcinogenesis 1991, 12, 2147-2150.
Weed et al., Carcinogenesis 1985, 6, 1239-1241.
Witschi et al., Carcinogenesis 1989, 10, 2275-2277.
Yavelow et al., Proc. Natl. Acad. Sci. USA 1985, 82, 5395-5399.

Affiliated with

Also associated with

Rating

Bowman-Birk inhibitor product for use as an anticarcinogenesis a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bowman-Birk inhibitor product for use as an anticarcinogenesis a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bowman-Birk inhibitor product for use as an anticarcinogenesis a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-950415